发明公开
EP1091941A1 NOVEL BENZIMIDAZOLES AS CORTICOTROPIN RELEASE FACTOR ANTAGONISTS
审中-公开
的苯并咪唑作为反对者皮质激素释放因子
- 专利标题: NOVEL BENZIMIDAZOLES AS CORTICOTROPIN RELEASE FACTOR ANTAGONISTS
- 专利标题(中): 的苯并咪唑作为反对者皮质激素释放因子
-
申请号: EP99932151.6申请日: 1999-07-01
-
公开(公告)号: EP1091941A1公开(公告)日: 2001-04-18
- 发明人: BECK, James, P. , CURRY, Matthew, A.
- 申请人: Du Pont Pharmaceuticals Company
- 申请人地址: 974 Centre Road, WR-1st 18 Wilmington, DE 19807 US
- 专利权人: Du Pont Pharmaceuticals Company
- 当前专利权人: Du Pont Pharmaceuticals Company
- 当前专利权人地址: 974 Centre Road, WR-1st 18 Wilmington, DE 19807 US
- 代理机构: Jones, Alan John
- 优先权: US91575P 19980702
- 国际公布: WO0001675 20000113
- 主分类号: C07D235/08
- IPC分类号: C07D235/08 ; C07D235/26 ; C07D401/04 ; A61K31/415
摘要:
The present invention describes novel benzimidazoles of formula (I) wherein D is an aryl or heteroaryl group, or pharmaceutically acceptable salt forms thereof, which are useful as CRF antagonists.
信息查询